Biomarkers 2012

Date
Start Date: 
Wednesday, September 26, 2012
End Date: 
Wednesday, September 26, 2012

London:


Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading companies showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. 



Book your seats online here http://www.virtueinsight.com/pharma/Biomarkers-2012/ 

Key Themes Discussed at this Conference: 
• Biomarker Discovery & Validation - Government policies & strategies 
• Companion Diagnostics & Personalized Medicine 
• Safety & Biomarkers in Clinical Development 
• Enabling Technologies to Maximise Biomarker Identification 
• Discuss how biomarkers can accelerate your clinical development 
• Design strategies for success in early phase trials 
• Showing clinical utility of biomarkers to improve diagnosis & make informed decision making 
• See how improvements in technologies are leading to better efficiency of biomarkers 
• Analyze biomarkers and their role in drug development 
• Development and Application of Clinical Safety Biomarkers with a focus on imaging biomarkers
• Assess preclinical safety considerations 
• Identifying current developments in Biomarkers & ways to overcome threats 
• Discovering successful business models - Opportunities & Challenges 
• Emerging stratified medicine via successful partnerships 
• Network in our combined exhibition and catering area 
• Evening networking reception for all attendees 


Key Speakers: 
• Mark Broenstrup, Director Biomarkers & Diagnostics, Sanofi-Aventis 
• Joachim Reischl, Head Global Biomarker Strategy and Development, Bayer Pharma 
• Jochen Theis, Owner & Principal Consultant, InHeCon (Germany) – Former Global Head, Biomarkers, F. Hoffmann-La Roche 
• David W. Moskowitz, Chairman, CEO & CMO, GenoMed (USA) 
• John Lambert, Vice President and Chief Medical Officer Clinical Pharmacology, Parexel 
• Sylvie Le Glédic, Director, Voisin Consulting Life Sciences 
• Mohamed Oubihi, EU Regulatory Intelligence Lead, International Regulatory Affairs, Biogen Idec 
• Malcolm I Mitchell, Senior Medical Fellow, Clinical Pharmacology, Eli Lilly 
• Austin Tanney, Scientific Liaison Manager, Almac Diagnostics 
• Eugenii (Ilan) A. Rabiner, Head, Imaging Applications & CMO, Imanova 
• Lincoln Tsang, Partner, Arnold & Porter LLP 
• Maria Hernandez Fuentes, Senior Lecturer in Translational Research, L.O.R.D. lab. MRC Centre for Transplantation, King's College London 

Plus Many More... 

ArticleTools